| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
11,450,000 |
| Market
Cap: |
7.54(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2893 - $1.35 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Monopar Therapeutics is a biopharmaceutical company focused on developing proprietary therapeutics for cancer patients. Co.'s compounds in development: Validive®, a Phase 2b/3 clinical stage, mucoadhesive buccal tablet for the prevention of radiation induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin, a Phase 1b clinical stage analog of doxorubicin engineered specifically to retain anticancer activity while minimizing toxic effects on the heart; MNPR-101, a preclinical stage uPAR-targeted antibody being developed as a radioimmunotherapeutic and companion diagnostic for cancers and COVID-19; and an early stage camsirubicin analog, MNPR-202, for various cancers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
16,053 |
| Total Buy Value |
$0 |
$0 |
$0 |
$49,659 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Robinson Chandler |
Chief Executive Officer |
• • – |
2024-03-31 |
4 |
D |
$0.68 |
$4,884 |
D/D |
(7,172) |
166,131 |
|
- |
|
| Robinson Chandler |
Chief Executive Officer |
• • – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,474 |
173,303 |
|
- |
|
| Tsuchimoto Kim R |
Chief Financial Officer |
• • – |
2024-03-31 |
4 |
D |
$0.68 |
$2,780 |
D/D |
(4,082) |
50,470 |
|
- |
|
| Tsuchimoto Kim R |
Chief Financial Officer |
• • – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,956 |
54,552 |
|
- |
|
| Cittadine Andrew |
Chief Operating Officer |
• • – |
2024-03-31 |
4 |
D |
$0.68 |
$2,110 |
D/D |
(3,098) |
57,624 |
|
- |
|
| Cittadine Andrew |
Chief Operating Officer |
• • – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,952 |
60,722 |
|
- |
|
| Robinson Chandler |
Chief Executive Officer |
• • – |
2024-01-01 |
4 |
D |
$0.34 |
$792 |
D/D |
(2,327) |
148,829 |
|
- |
|
| Robinson Chandler |
Chief Executive Officer |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,724 |
151,156 |
|
- |
|
| Tsuchimoto Kim R |
Chief Financial Officer |
• • – |
2024-01-01 |
4 |
D |
$0.34 |
$172 |
D/D |
(505) |
44,596 |
|
- |
|
| Tsuchimoto Kim R |
Chief Financial Officer |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,231 |
45,101 |
|
- |
|
| Starr Christopher M |
Director |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,533 |
25,863 |
|
- |
|
| Robinson Chandler |
Chief Executive Officer |
• • – |
2023-12-31 |
4 |
D |
$0.34 |
$2,881 |
D/D |
(8,469) |
144,432 |
|
- |
|
| Robinson Chandler |
Chief Executive Officer |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,474 |
152,901 |
|
- |
|
| Klausner Arthur J |
Director |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,533 |
30,863 |
|
- |
|
| Tsuchimoto Kim R |
Chief Financial Officer |
• • – |
2023-12-31 |
4 |
D |
$0.34 |
$1,386 |
D/D |
(4,073) |
43,870 |
|
- |
|
| Tsuchimoto Kim R |
Chief Financial Officer |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,957 |
47,943 |
|
- |
|
| Cittadine Andrew |
Chief Operating Officer |
• • – |
2023-12-31 |
4 |
D |
$0.34 |
$1,054 |
D/D |
(3,098) |
51,770 |
|
- |
|
| Cittadine Andrew |
Chief Operating Officer |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,952 |
54,868 |
|
- |
|
| Anderson Raymond |
Director |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,533 |
26,863 |
|
- |
|
| Brown Michael J |
Director |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,533 |
235,863 |
|
- |
|
| Tsuchimoto Kim R |
Chief Financial Officer |
• • – |
2023-09-30 |
4 |
D |
$0.62 |
$2,135 |
D/D |
(3,444) |
37,986 |
|
- |
|
| Tsuchimoto Kim R |
Chief Financial Officer |
• • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,956 |
41,430 |
|
- |
|
| Robinson Chandler |
Chief Executive Officer |
• • – |
2023-09-30 |
4 |
D |
$0.62 |
$4,446 |
D/D |
(7,172) |
128,427 |
|
- |
|
| Robinson Chandler |
Chief Executive Officer |
• • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,474 |
135,599 |
|
- |
|
| Cittadine Andrew |
Chief Operating Officer |
• • – |
2023-09-30 |
4 |
D |
$0.62 |
$1,627 |
D/D |
(2,624) |
45,916 |
|
- |
|
155 Records found
|
|
Page 1 of 7 |
|
|
0.03 (4.89%) 
